Tag: entrepreneurs
-
Infographic – Corp. Venture Investments Dip in 2022
Venture capital investments by corporations in start-ups declined globally in 2022, but remained at historically high levels, while the number of deals stayed about the same as 2021.
-
Start-Up Creating Software to Simplify Biomedical Analytics
A new enterprise began public operations to provide researchers with better analytical tools for making sense of mountains of complex genomics and related biomedical data.
-
Autism Device Company Gains Venture Funds, Joins Incubator
A new company creating precision light-activated treatments for autism spectrum disorder symptoms is raising more seed funds and joining a start-up incubator program.
-
New Venture Funds to Back Life Science, Tech Start-Ups
Three new venture funds are seeking to invest up to $6.3 billion in start-up companies with advances in life sciences, health care, energy, and information technologies.
-
Trial Underway Testing Bioelectronic Incontinence Device
The first participants are enrolled in a clinical trial of an implanted bio-feedback device to help women control urinary incontinence, sudden or stress-related urges to urinate.
-
Damaged Human Lungs Restored for Transplantation
A research team demonstrated the feasibility of connecting anesthetized pigs to human lungs deemed unfit for transplants, for recovering the lungs to transplant quality.
-
Infographic – Digital Health Venture Funds Crater in Q4 2022
Venture funds for new companies developing digital solutions for health care continued dropping throughout 2022, reaching their lowest levels in years in the fourth quarter.
-
Types of Tax Forms for Businesses
This post lists the major tax forms a business owner should consider while preparing tax information.
-
Infographic – 2022 Biotech Venture Funding Weakens
Venture funds for new U.S. biotechnology and pharmaceutical companies declined from historical highs in 2022, but a closer look reveals even more signs of financial tightening.
-
Environmental Biomarker Start-Up Gains $16M in Early Funds
A new company developing diagnostics for neurological and other disorders based on environmental exposures is raising $16 million in venture funds.